| 7.75 0.23 (3.06%) | 05-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.52 | 1-year : | 10.29 |
| Resists | First : | 8.15 | Second : | 8.81 |
| Pivot price | 7.98  |
|||
| Supports | First : | 7.09 | Second : | 5.9 |
| MAs | MA(5) : | 7.69 |
MA(20) : | 7.93 |
| MA(100) : | 9.27 |
MA(250) : | 11.11 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 34.7 |
D(3) : | 31.8 |
| RSI | RSI(14): 50.5 |
|||
| 52-week | High : | 17.74 | Low : | 5.93 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ DRIO ] has closed above bottom band by 43.3%. Bollinger Bands are 44.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 7.91 - 7.95 | 7.95 - 7.98 |
| Low: | 7.43 - 7.47 | 7.47 - 7.51 |
| Close: | 7.83 - 7.9 | 7.9 - 7.96 |
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Tue, 26 May 2026
Hypertension digital program deal lets DarioHealth reach 500,000 people - Stock Titan
Fri, 15 May 2026
DarioHealth Corp. (DRIO) reports Q4 loss, beats revenue estimates - MSN
Thu, 14 May 2026
DarioHealth Corp. (NASDAQ:DRIO) Q1 2026 Earnings Call Transcript - Insider Monkey
Wed, 13 May 2026
DarioHealth Reports First Quarter 2026 Financial and Operating Results - PR Newswire
Wed, 13 May 2026
DarioHealth Corp (DRIO) Q1 2026 Earnings Call Highlights: Navigating Growth and Strategic ... By GuruFocus - Investing.com Canada
Wed, 13 May 2026
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 7 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 21.1 (%) |
| Held by Institutions | 10.8 (%) |
| Shares Short | 67 (K) |
| Shares Short P.Month | 66 (K) |
| EPS | -10.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.84 |
| Profit Margin | -186.6 % |
| Operating Margin | -163.7 % |
| Return on Assets (ttm) | -20.1 % |
| Return on Equity (ttm) | -59.7 % |
| Qtrly Rev. Growth | -31.3 % |
| Gross Profit (p.s.) | 1.96 |
| Sales Per Share | 3.06 |
| EBITDA (p.s.) | -4.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -26 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.79 |
| PEG Ratio | 0 |
| Price to Book value | 0.8 |
| Price to Sales | 2.57 |
| Price to Cash Flow | -2.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|